| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |